PD1-TIL
- Generic Name
- PD1-TIL
Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03347097
- Locations
- 🇨🇳
Huashan hospital, Fudan University, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath